← Back to Clinical Trials
Recruiting NCT07109492

NCT07109492 The Role of Mandala Painting Before Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07109492
Status Recruiting
Phase
Sponsor Niran Çoban
Condition Mandala Painting
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-07-01
Primary Completion 2026-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Mandala

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-07-01 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Surgical interventions often cause significant anxiety and stress in patients during the preoperative period. In this study, it is aimed to determine the effect of mandala coloring, a non-pharmacological and art-based intervention, on reducing anxiety and stress levels in individuals scheduled for elective surgery. The universe of the study will consist of patients who will undergo elective surgery between June 2025 and June 2026 in the General Surgery Clinic of Istanbul Sultangazi Training and Research Hospital. Data will be collected using the Introductory Information Form, State Anxiety Inventory (STAI-S), Perceived Stress Scale (PSS), and Physiological Parameters Form (including blood pressure, pulse, respiration rate, and oxygen saturation). One day before surgery, patients who meet the inclusion criteria will be informed about the study and randomized into intervention and control groups using a random number table created with MS Excel software. Patients in the intervention group will perform a 20-minute mandala coloring activity in the preoperative waiting period. Before and after the application, participants' anxiety and stress levels will be evaluated with the STAI-S and PSS, and their physiological parameters will be recorded. Patients in the control group will receive standard preoperative care and will be evaluated at the same time points with the same tools, without any intervention. The study aims to provide evidence for the use of mandala coloring as a simple, low-cost, and effective nursing intervention to reduce preoperative anxiety and stress.

Eligibility Criteria

Inclusion Criteria: * Individuals who are undergoing elective surgery, * Cholecystectomy Surgery is planned * Age 18 and over, * Able to communicate, * No wounds or injuries on their hands that would prevent them from painting, * Volunteer to participate in the study. Exclusion Criteria: * Individuals with a previous psychiatric diagnosis, * Those with color blindness or visual perception disorders, Patients over 70 years of age * Those taking tranquilizers (anxiolytics, antidepressants, etc.), * Those with any health problems that may prevent them from painting (fractures, amputations, etc.), * Those who are illiterate, * Those with communication disabilities will be excluded from the study.

Contact & Investigator

Central Contact

NİRAN ÇOBAN

✉ nirancoban@gmail.com

📞 05301586912

Principal Investigator

NİRAN ÇOBAN

STUDY DIRECTOR

University of Yalova

Frequently Asked Questions

Who can join the NCT07109492 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Mandala Painting. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07109492 currently recruiting?

Yes, NCT07109492 is actively recruiting participants. Contact the research team at nirancoban@gmail.com for enrollment information.

Where is the NCT07109492 trial being conducted?

This trial is being conducted at Yalova, Turkey (Türkiye).

Who is sponsoring the NCT07109492 clinical trial?

NCT07109492 is sponsored by Niran Çoban. The principal investigator is NİRAN ÇOBAN at University of Yalova. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology